These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31424014)

  • 1. Colistin-sparing approaches with newer antimicrobials to treat carbapenem-resistant organisms: Current evidence and future prospects.
    Veeraraghavan B; Pragasam AK; Bakthavatchalam YD; Anandan S; Swaminathan S; Sundaram B
    Indian J Med Microbiol; 2019; 37(1):72-90. PubMed ID: 31424014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of newer colistin-sparing antimicrobial agents for clinical isolates of carbapenem-resistant organisms.
    Saxena S; Aggarwal P; Mitra S; Singh S; Kaim M; Sharma A
    J Infect Chemother; 2024 Dec; 30(12):1252-1258. PubMed ID: 38839032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid spread of carbapenem-resistant Enterobacteriaceae.
    Potter RF; D'Souza AW; Dantas G
    Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study.
    Büchler AC; Gehringer C; Widmer AF; Egli A; Tschudin-Sutter S
    Euro Surveill; 2018 Jul; 23(30):. PubMed ID: 30064544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
    Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
    ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
    Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
    Berçot B; Poirel L; Dortet L; Nordmann P
    J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in
    Haidar G; Clancy CJ; Shields RK; Hao B; Cheng S; Nguyen MH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of a multidrug-resistant clinical isolate of Escherichia coli ST8499 strain producing NDM-13 carbapenemase in the Republic of Korea.
    Kim JS; Jin YH; Park SH; Han S; Kim HS; Park JH; Gong Y; An JH; Jung SW; Kim S; Kim J; Kim DW; Hong CK; Lee JH; Kim IY; Jung K
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):410-412. PubMed ID: 30879710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey.
    Süzük Yıldız S; Kaşkatepe B; Şimşek H; Sarıgüzel FM
    Acta Microbiol Immunol Hung; 2019 Mar; 66(1):103-112. PubMed ID: 30403361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.